Zebrafi sh can provide a valuable animal model to screen potential cognitive enhancing and anxiolytic drugs. They are economical and can provide a relatively quick indication of possible functional effi cacy. In as much as they have a complex nervous system and elaborate behavioral repertoire, zebrafi sh can provide a good intermediate model between in vitro receptor and cell-based assays and classic mammalian models for drug screening. In addition, the variety of molecular tools available in zebrafi sh makes them outstanding models for helping to determine the neuromolecular mechanisms for psychoactive drugs. However, to use zebrafi sh as a translational model we must have validated, sensitive and effi cient behavioral tests. In a series of studies, our lab has developed tests of cognitive function and stress response, which are sensitive to drug effects in a similar manner as rodent models and humans for cognitive enhancement and alleviating stress response. In particular, the three-chamber task for learning and memory was shown to be sensitive to the cognitive enhancing effects of nicotine and has been useful in helping to determine neural mechanisms crucial for nicotinic-induced cognitive enhancement. The novel tank diving test was shown to be a valid and effi cient test of stress response. It is sensitive to the reduction in stress-related behaviors due to the amxiolytic drugs diazepam and buspirone but not chlordiazepoxide. Nicotine also causes stress alleviating effects which can be interpreted as anxiolytic effects. Zebrafi sh models of behavioral pharmacology can be useful to effi ciently screen test compounds for drug development and can be useful in helping to determine the mechanisms crucial for new therapeutic treatments of neurobehavioral impairments.
Introduction
Zebrafi sh offer an outstanding model to provide a screen for neurobehavioral disorders (Stewart et al. , 2010 ) as well as potential psychotherapeutic drugs (Rihel et al. , 2010 ) and the crucial mechanisms for the psychotherapeutic effects. Recently, zebrafi sh larvae motility assays have been found to be rather useful for an initial drug screen for psychotherapeutic drug candidates (Rihel et al. , 2010 ) . Zebrafi sh have long been used as an important model for studying developmental biology in general and neurobiology in particular (Schier , 1997 ) . Molecular mechanisms of behavioral function can be studied in zebrafi sh with the use of the great variety of mutant lines available. In addition, morpholinos can be used to reversibly suppress the expression of individual genes during early development. Specifi c reporter systems and continuous visual access during development provides considerable availability of the developmental process. The same molecular tools useful for studying neurodevelopment are key for the use of zebrafi sh for screening psychotherapeutic drugs and determining crucial neuromolecular and cellular mechanisms. Much more opportunity remains to be pursued in the study of molecular mechanisms of drug actions on behavioral function in zebrafi sh.
This paper reviews a series of studies we have done over the past decade in order to develop tests of cognitive and emotional function in zebrafi sh and use those tests to determine the effects of drugs known to affect these functions in mammals. The goal of this research is to develop the zebrafi sh model to test the effects of drug candidates as a precursor to later research in mammals. It is envisioned that zebrafi sh characterized in these behavioral tests and a variety of others developed in the fi eld would provide crucial information in the drug development process after initial characterization using receptor and cell-based assays and prior to classic rodent assays. It is intended that by providing proof of concept information concerning drug effects on complex neurobehavioral function in an economical rapid test system, zebrafi sh can help identify promising candidates from the hundreds of compounds that clear the receptor and cell-based assays and provide the rodent assay effort with a smaller, more manageable number of candidates.
Crucial to constructing a zebrafi sh model which is useful for development of psychotherapeutic drugs is the use of behavioral tests that are reliable, valid and effi cient. Over the past decade, we have developed such tests for assessment of learning and memory in the three-chamber task as well as stress response in the novel tank diving test and have used these tests to assess the effi cacy of drug treatments as described below. Both of these tests have proven to be useful in our studies. However, there are a variety of ways to measure these behavioral functions as has been demonstrated in the important work of many other investigators.
Other labs have contributed greatly to the effort to develop the zebrafi sh model for investigation of the neural bases of cognitive function and stress response as well as for screening the effi cacy of potential therapeutic drugs. A variety of cognitive tasks of various types have been developed. Using a T-maze with an enriched environment at the end of one choice arm it was shown that zebrafi sh would readily learn spatial discrimination (Darland and Dowling , 2001 ) . A T-maze has also been used to demonstrate color discrimination of zebrafi sh for appetitive reinforcement (Colwill et al. , 2005 ; Zhdanova et al. , 2008 ) . A delayed spatial alternation paradigm for appetitive reinforcement has been used to index spatial working memory in zebrafi sh (Williams et al. , 2002 ) and ethanol has been shown to produce dose-dependent choice accuracy impairments (Carvan et al. , 2004 ) . Zebrafi sh have been shown to have signifi cant learning using olfactory cues (Braubach et al. , 2009 ) .
Interestingly, the sight of conspecifi cs can be used as reward in associative learning in zebrafi sh (Al -Imari and Gerlai, 2008 ; G ó mez-Laplazaa and Robert Gerlaib, 2009 ) . Several studies have shown the effi cacy of classic two-chamber shuttle box active-avoidance learning (Pradel et al. , 1999 (Pradel et al. , , 2000 Xu et al. , 2007 ; Pather and Gerlai , 2009 ) . This is rather effi cient at rapidly determining acquisition of a response, but does have the drawback of not having a differential measure of response speed and choice accuracy. In an active response task hyperactivity would be advantageous, whereas in a passive avoidance task sedation would be advantageous. We have used a three-chamber task with a central start chamber and two side chambers presenting choice alternatives with equal swimming needed for each choice to index learning and memory in zebrafi sh.
Pharmacological studies investigating the case of nicotinic involvement in cognitive function were conducted. Nicotinic receptors of several types have been identifi ed in zebrafi sh (Zirger et al. , 2003 ) . Nicotinic agonist and antagonist effects on learning and memory, dose-and time-effect functions and the relationship of nicotinic effects to changes in monoaminergic neurotransmitter systems were determined.
Stress response and by inference anxiety have been widely studied in zebrafi sh in recent years and a variety of welldesigned test methods have been developed [see recent reviews: (Cachat et al. , 2011 ; Gerlai , 2010 ; Maximino et al. , 2010 ) ]. Useful test paradigms include shoaling response (grouping together of fi sh), predator avoidance and light-dark environment choice (Engeszer et al. , 2004 ; Miller and Gerlai , 2007 ; Bass and Gerlai , 2008 ; Egan et al. , 2009 ; Gerlai et al. , 2009 ; Champagne et al. , 2010 ; Sackerman et al. , 2010 ) in addition to the novel tank diving task described in this article. Anxiety is a description of an adverse subjective state in people. As such, it cannot be directly measured in experimental animal models. However, behavioral tests of stress response, which are sensitive to anxiogenic and anxiolytic environmental and pharmacological manipulations in people can be used in animal models to help identify the neural bases of anxiety as well as possible new anxiolytic treatments. Predatory avoidance can be measured in several ways: fl eeing, freezing, shoaling and thigmotaxis (dwelling near a wall or bottom of the tank). Several studies have used shoaling behavior that zebrafi sh show when threatened as an index of stress response vs. dispersal, which is more optimal for feeding (Miller and Gerlai , 2008 ) . Predator threat paradigms have been developed in which the zebrafi sh respond by increasing swimming in reaction to a displayed image of a predator (Blaser and Gerlai , 2006 ) . Drug withdrawal anxiogenesis has been demonstrated in zebrafi sh. Cocaine withdrawal caused hyperactive swimming and motor stereotypy indicative of anxiety . Recently, Kalueff and coworkers (Egan et al. , 2009 ) used a very similar assessment of the diving response that we have used in studies reviewed below. They also found that zebrafi sh reliably make a diving response in a novel environment and that the duration of this diving response can be used to study the neurobehavioral bases of stress response. They showed that acute exposure to alarm pheromone or caffeine increased stress-related behavioral effects and that chronic exposure to the antidepressant drug fl uoxetine decreased them.
In this article, we present a series of studies we have conducted to develop and optimize methods for assessing cognitive functions such as learning and memory as well as stress response. We have developed a three-chamber task, which is rather fl exible and can be used to index spatial learning, reversal learning, response alternation learning and memory. Pharmacological characterization has been made for nicotinic cholinergic systems using nicotinic agonist and antagonist treatments and neurochemical characterization has been done for the monoaminergic transmitters. A method assessing stress response behavior has been developed taking advantage of the tendency of prey fi sh to dive to the bottom of a novel environment and then over time as they become more familiar with the safety of the environment, they swim more toward the upper levels of the environment. This diving response has been shown to be specifi c to a novel vs. familiar environment. Classic and atypical anxiolytic drugs as well as nicotine and nicotinic antagonist treatments were used to pharmacologically characterize the test. These tests add to our ability to screen novel cognitive enhancing and anxiolytic drug candidates and the crucial mechanisms for these effects. This review presents the work we have done over the past 10 years to develop, validate and use zebrafi sh behavioral tests of cognition and emotion for use in drug development research for cognitive enhancing and anxiolytic drugs.
Results

The three-chamber task
Nicotine administration at low to moderate doses increased delayed spatial alternation accuracy in the three-chamber task, indicating improved spatial working memory (Levin and Chen, 2004 ) . As shown in Figure 1 , the dose-effect function for nicotine effects on memory in zebrafi sh showed an inverted J-shaped dose-response curve with a signifi cant ( p < 0.005) linear effect over dose with nicotine treatment improving choice accuracy relative to control performance at lower nicotine doses and this effect trailing off with higher doses. The 50 and 100 mg/l doses each caused a signifi cant ( p < 0.05) improvement in accuracy relative to control.
Nicotine also increased accuracy in simple spatial discrimination learning (Levin et al. , 2006a ; Eddins et al. , 2009 ). This is a fairly rapid test with only a single session of training the fi sh to go to its non-preferred side of the tank. In this task nicotine caused signifi cant improvement in choice accuracy with 100 ( p < 0.01) and 200 mg/l ( p < 0.05) for 3 min immersion; however, 50 mg/l was not effective with dosing 40 min before testing. A detailed time-effect function was assessed for the benchmark of 100 mg/l nicotine dose. As shown in Figure  2 , nicotine had a delayed time-effect function for improving spatial learning (Levin et al. , 2006a ) . Improvement was not seen immediately after dosing but only became signifi cant starting with a delay of 20 min post-dosing ( p < 0.05) and persisting until 40 min post-dosing ( p < 0.01). Clearly no differences in choice accuracy were seen immediately after dosing or 5 min later. A suggestion of improvement was apparent 10 min post-dosing but this was not signifi cant. The nicotineinduced improvement dissipated after 40 min post-dosing with no improvement detected at 80 or 160 min after dosing. This time-effect function for choice accuracy contrasted with the quicker nicotine effect on choice latency, which showed signifi cant nicotine-induced increases at 5 ( p < 0.025) and 20 ( p < 0.001) min post-dosing but not before or after.
The non-competitive nicotinic antagonist mecamylamine (200 mg/l for 3 min) reversed the nicotine-induced improvement when it was administered after nicotine exposure just before testing but not when administered together with nicotine 40 min before testing ( Figure 3 ) showing that nicotinic receptor blockade did not antagonize the induction of the nicotine-induced learning improvement, whereas it did antagonize the expression of the effect (Levin et al. , 2006a ) . This is consistent with the hypothesis that the nicotine-induced learning improvement was not due to nicotinic receptor activation. This would have been blocked by concurrent mecamylamine. Rather, the nicotine-induced learning improvement could have been due to the nicotine-induced receptor desensitization, which would not have been blocked by concurrent mecamylamine and subsequent recovery from desensitization prior to testing, which would have been blocked by Figure 1 Nicotine dose-effect function for improving memory in the three-chamber spatial alternation task (mean ± sem) (Levin and Chen, 2004 ) . Relative to control percent accuracy (percent correct after nicotine treatment-percent correct after vehicle) on the delayed spatial alternation task there was a signifi cant ( p < 0.005) decrease in accuracy with increasing acute nicotine doses from improvement with lower dose to impairment with higher doses (n = 12). The 50 and 100 mg/l doses each caused a signifi cant ( p < 0.05) improvement in accuracy relative to control.
Figure 2
Nicotine delayed time-effect function for improving spatial discrimination (mean ± sem) (Levin et al. , 2006a ) . There was a delayed improvement in simple spatial discrimination in the three-chamber task, which became signifi cant 20 min after the end of nicotine exposure and continued to be signifi cant up to 80 min after the end of exposure.
Figure 3
Blockade of nicotine effect with the nicotinic antagonist mecamylamine (mean ± sem) (Levin et al. , 2006a ) . This shows a replication of the signifi cant improvement in choice accuracy in the simple spatial discrimination in the three-chamber task caused by 100 mg/l nicotine given by immersion for 3 min ending 40 min before testing. Mecamylamine given concurrently with nicotine (200 Early) was not effective in reversing this improvement. The same mecamylamine dose given 5 min before testing (200 Late) did successfully reverse the improvement caused by nicotine given 40 min before testing, even though administration of mecamylamine alone at this point did not impair performance. response and no change over the 5-min test session ( Figure  5 ). This resulted in a very signifi cant ( p < 0.0001) interaction of housing condition × minute of the test (Bencan et al. , 2009 ) . It can be posited that it is not the novelty but the stress of being transferred from the wide to the narrow tank that provoked the diving response. However, it does seem that it is the novelty which induces the diving response. Recently we have determined the effect of repeated testing the novel tank diving task and found that the diving response is only seen on the fi rst 5-min session of testing (session mean = 30.1 ± 6.3 s/min in the bottom third of the tank) with signifi cantly ( p < 0.005) less diving on the second test (session mean = 8.6 ± 3.5 s/min in the bottom third of the tank) (Levin et al. , 2010 ) .
The test also proved to be sensitive to anxiolytic drugs. The classic anxiolytic drug diazepam produced a signifi cant anxiolytic-like effect in the novel tank diving test ( Figure  6 ) (Bencan et al. , 2009 ). The effect was non-monotonic with moderate but not high or low doses being effective. The effective doses of diazepam for signifi cantly reducing the diving response were 1.25 mg/l ( p < 0.05) and 5 mg/l ( p < 0.05). Curiously, the intermediate dose of 2.5 mg/l was not found to cause a signifi cant reduction. This could have been the result of beta error in which a true effect is not detected because of variability of response. Analysis of variance effectively protects against alpha error (mistakenly concluding that there is an effect when in fact there is none) but not beta error. The atypical anxiolytic buspirone also produced an anxiolytic-like effect in this test (Figure 7 ) (Bencan et al. , 2009 ). The buspirone effect was monotonic. Both of these anxiolytic effects were seen at doses that did not cause sedation as indicated by measurements of locomotor speed. By contrast, the anxiolytic drug chlordiazepoxide was not mecamylamine given shortly before testing. This sequence of events would also be consistent with the delayed induction of the nicotine-induced learning improvement. Dopamine appears to be important for spatial learning in the zebrafi sh and for nicotine effects on that learning. In the same way that mecamylamine blocks the expression of nicotine-induced learning improvement when given after nicotine exposure, the same dose and timing of mecamylamine blocks nicotine-induced increases in the dopamine metabolite DOPAC (Eddins et al. , 2009 ). In addition, there is a robust positive correlation of spatial discrimination choice accuracy between the three-chamber task and brain DOPAC concentration (Figure 4 ) regardless of nicotine exposure (Eddins et al. , 2009 ). We did not see relationships between nicotine effects on learning in the three-chamber task and serotonin or norepinephrine systems.
The novel tank diving test
The novel tank diving test (Levin and Cerutti , 2008 ) was used to assess anxiolytic effects of drugs. Behavioral validation of the novel tank diving test was conducted to determine the impact of novelty on the diving response. Figure 5 shows that even with testing in identical test tanks, fi sh transferred from a different tank vs. the same type of tank the fi sh which had been living in the larger tank showed a diving response when initially placed in the test tank, whereas the fi sh which had been living in the same-sized tank as the test tank did not show this response when transferred into the test tank. The fi sh transferred from the wider home tank to the narrow test tank showed a greater initial diving response followed over the next 5 min by greater exploration of the higher levels of the test tank. By contrast, the fi sh which had been hosed in an identically sized tank as the test tank showed less diving Figure 4 Correlation of learning spatial discrimination in the threechamber task and whole brain DOPAC levels (pg/g tissue).
There was a signifi cant ( p < 0.001) increase in accuracy on the simple spatial discrimination in the three-chamber task associated with increases in whole brain concentrations of the dopamine metabolite DOPAC (Eddins et al. , 2009 ). The nicotine exposure concentration was 100 mg/l for 3 min immersion ending 20 min before testing. Sacrifi ce occurred just after testing. Figure 5 Behavioral validation of the novel tank diving test demonstrating the effect of novelty (mean ± sem) (Bencan et al. , 2009 ) . Zebrafi sh housed in 3-l wide tanks when tested in the novel 1.5-l narrow tanks showed the novel tank diving response and recovery over the 5-min session in which they spent the great majority of time in the bottom of the tank shortly after introduction to the tank and then spent progressively less time at the bottom as they explored the upper levels with longer experience in the new tank. By contrast, the zebrafi sh housed in the narrow 1.5-l tanks did not show a change in position across the 5-min session.
seen to be anxiolytic in this assay with zebrafi sh, even though a broad dose range was tested including doses which were non-sedative up through clearly sedative doses (0.625, 1.25, 2.5, 5, 10 and 20 mg/l).
Nicotine, which has been shown in rats and humans to have anxiolytic effects, clearly showed anxiolytic-like effects in the novel tank diving test in zebrafi sh. As shown in Figure 8 nicotine reduced bottom dwelling in the novel tank diving test (Levin et al., 2007 ) . This effect was seen at a dose (immersion in 100 mg/l for 3 min), which also caused signifi cant 
Figure 7
Buspirone decreases bottom dwelling in the 5-min novel tank diving test (mean ± sem) (Bencan et al. , 2009 ). The numbers were 10 per treatment condition. Over the dose range tested there was a monotonic dose-effect function with 6.25 ( p < 0.05), 25 ( p < 0.01) and 50 mg/l ( p < 0.01) doses causing a signifi cant decrease in bottom dwelling. improvement in cognitive function. Therefore, the effect of inhibiting the diving response did not seem to be merely due to confusion or disorientation of the fi sh. A lower dose of 50 mg/l caused a signifi cant reduction in diving response during the initial portion of the session when controls show the greatest diving response. The anxiolytic effect was reversed by administration of the noncompetitive antagonist mecamylamine (Levin et al., 2007) . More specifi c antagonists, methyllycaconitine HCl (MLA) and dihydro-β -erythroidine HCl (DH β E), which competitively block α 7 and α 4 β 2 receptors, respectively, were also effective in reversing the nicotine actions (Bencan and Levin , 2008 ) .
Discussion
Zebrafi sh have thus far shown great promise as a complementary vertebrate model for studying the neural bases of cognitive function and stress response. The zebrafi sh model could be rather useful for screening possible new treatments for cognitive and anxiety disorders. Zebrafi sh can serve as an important intermediate model between in vitro cell-based assays and classic rodent models. Zebrafi sh share the economy and ease of access as in vitro models, but they also have the complex anatomy and temporal specifi city crucial to brain function that is present in rodent models. To make the best use of the zebrafi sh model we need to have reliable, effi cient, sensitive and valid behavioral tests. Our studies and others have developed new methods for behavioral analysis of cognitive function and stress response in zebrafi sh that can be used to study these functions and their neural bases as well as to serve as a valuable screen for new drug development.
The three-chamber task has proven to be a fl exible, reliable and sensitive method for assessing learning and memory in zebrafi sh. It is relatively effi cient for a manual test with a reliable index of learning ability available with a single session of testing for spatial discrimination. In agreement with other Figure 8 Nicotine reduces bottom dwelling in the 5-min novel tank diving test (mean ± sem) (Levin et al., 2007) . The numbers were 10 per treatment condition. The 50 mg/l nicotine dose only caused a signifi cant ( p < 0.05) attenuation of initial diving during the fi rst minute, whereas the 100 mg/l dose caused a decrease in bottom dwelling during the entire test period ( p < 0.05 to p < 0.0001).
investigators (Hicks et al. , 2006 ) , computerized cognitive testing for zebrafi sh is the goal for future research to make the three-chamber task automated for greater economy and higher throughput.
This line of research showed the utility of the three-chamber task for indexing zebrafi sh learning of spatial discrimination, color discrimination, color reversal and delayed spatial alternation test of working memory function. The delayed spatial alternation memory task was useful in demonstrating the non-monotonic dose-effect function with nicotine. This task showed the same low-dose cognitive facilitation with nicotine as seen in mammals such as rats, monkeys and humans (for review see: Levin et al. , 2006b ). Delayed spatial alternation is a good technique for assessing memory function, but it takes considerable training in zebrafi sh with a slow rate of acquisition (Levin and Chen, 2004 ) . Simple spatial discrimination is more suited to screening with only a single session of training.
Simple spatial discrimination learning provided a higher throughput assessment that permitted detailed investigation of the time-effect function of nicotine impacts on learning. The delayed onset of the nicotine-induced learning improvement suggested that the short-term receptor activation caused by nicotine might not be the mechanism underlying the learning improvement. This possibility was supported by the demonstration that concurrent application of the nicotinic antagonist mecamylamine did not block nicotine-induced cognitive improvement. Rather, it was later application of mecamylamine that blocked expression of the nicotine effect. This suggested that nicotinic receptor activation was not crucial for the induction of the effect but it was necessary for the expression of the effect. Our hypothesis is that it is the nicotinic receptor desensitization, which is not blocked by mecamylamine followed by later recovery of sensitivity for activation by acetylcholine, which is blockable by mecamylamine, that underlies nicotine-induced learning improvement. Dopamine systems have been in zebrafi sh from early development onward (Holzschuh et al. , 2001 ) . They have been shown to be important for locomotor activity (Anichtchik et al. , 2004 ) . The current studies also demonstrate the importance of dopamine systems in the zebrafi sh brain for cognitive function. Dopamine metabolite levels were found to have a robust positive linear relationship with accuracy in the spatial learning task. Nicotine-induced increase in dopamine metabolite levels corresponded with improved accuracy in the three-chamber task and the nicotinic antagonist reversed both the expression of the dopaminergic effect and improvement in maze choice accuracy.
The novel tank diving task proved useful for determining stress response. The test was validated with a comparison of fi sh housed in the same-sized tanks as the test tank vs. other fi sh housed in tanks larger than the test tank. Those fi sh being transferred from the larger tanks into the novel tank did show the diving response. There were mixed responses with benzodiazepine anxiolytic drugs. Diazepam did produce a signifi cant reduction of the novel tank diving response, but the effect was non-monotonic with intermediate but not higher or lower doses being effective. The doses of diazepam, which were effective in reducing the diving response, did not produce sedation, thus the decreased diving could not be attributed merely to slower response. The biphasic dose-response curve seen with diazepam in zebrafi sh with moderate but not higher or lower doses being effective has also been seen in rats on an elevated plus maze where only moderate diazepam signifi cantly increased time rats spent on the open arms of the maze (Ruarte and Alvarez , 1999 ) .
By contrast, another benzodiazepine chlordiazepoxide was not effective in reducing the novel tank diving response over a broad dose range from low doses that did not affect swimming speed all the way up to doses that caused substantial sedative response. The reason why chlordiazepoxide was not effective whereas diazepam was effective is not immediately clear. Both benzodiazepines facilitate GABA-A receptor actions via actions on benzodiazepine receptors (Atack , 2005 ) . These two drugs also have similar potencies at inhibiting high affi nity choline uptake (Miller and Richter , 1985 ) . It could be that the differential effects of these drugs at glycine receptors might be relevant with the greater than sevenfold greater potency of diazepam at the glycine receptor than chlordiazepoxide (Young et al. , 1974 ) . Also, chlordiazepoxide is more effective than diazepam at inhibiting thyrotropinreleasing hormone (Drummond , 1985 ) . Further research is necessary to determine whether these mechanisms or others are responsible for the differential effects of diazepam and chlordiazepoxide on the novel tank diving task.
The atypical antipsychotic buspirone was fully effective in reducing the novel tank diving response at doses that did not produce sedation showing that its effi cacy was not merely due to slower swimming. Finally nicotine, which is not a classic anxiolytic drug, but has been found under certain conditions in humans and mammalian models to reduce anxiety (Jarvik and Pomerleau , 1986 ; Picciotto et al. , 2002 ) , signifi cantly reduced the novel tank diving response. The effective dose of 100 mg/l was also effective in signifi cantly improving learning and memory in the three-chamber task. Thus, the nicotineinduced attenuation of the novel tank diving response was not merely due to disorientation. The zebrafi sh model can be very useful for the study of the neurobiological bases of a variety of behaviors as shown in the studies in our lab as well as many others in the fi eld. Our studies have found that zebrafi sh show cognitive and stressrelated behaviors that have important similarities to mammals. These can be studied in zebrafi sh both to help determine the mechanisms underlying these functions and how they can go awry, and also to help screen for drug treatments to help reverse cognitive and emotional impairments.
Materials and methods
Subjects
Zebrafi sh ( Danio rerio ) were kept at approximately 28.5 ° C on a 12:12-h light/dark cycle in an automated fl ow-through continuously fi ltered water system by Aquatic Habitats (Apopka, FL, USA). Behavioral testing of drug effects took place during the light phase between 8:00 h and 17:00 h. The fi sh were adults approximately 2 -4 months of age.
In each study the fi sh were randomly sorted into treatment groups and vehicle-treated controls. The tank water was made by mixing deionized H 2 O and sea salts (Instant Ocean, United Pet Group, Cincinnati, OH, USA, 1.2 g/20 l of H 2 O). The tanks with the groups of adult fi sh were maintained with constant fi ltration and aeration. Fish were fed twice daily with brine shrimp and fl ake fi sh food.
The three-chamber task for assessing learning and memory
The three-chamber task has a simple apparatus, which can be used to assess a variety of different types of learning as well as memory. The advantage of the three-chamber test over the two-chamber shuttle box is that the activity of the fi sh is not confounded with choice accuracy. The same amount of locomotion is needed for correct as for incorrect responses. This is not true for either active or passive avoidance in the two-chamber shuttle box paradigm. Figure 9 shows the most recent version of the three-chamber task apparatus (Eddins et al. , 2009 ) . Earlier studies used a larger version in a rectangular fi sh tank (Arthur and Levin , 2001 ; Levin et al. , 2003 Levin et al. , , 2006a . In brief, the apparatus has a central chamber with movable partitions on either side. The partitions were mounted on Plexiglas rails so that they could be moved to within 1 -2 cm from the end wall of the tank. Dark strips were placed along the rear side of the tank to provide an axis of orientation for position discrimination. The partitions can be opened to permit access for the fi sh to each of the two side chambers. Once the fi sh swims to one side or the other (a choice can be forced by bringing together the partitions), the gate can be closed. The fi sh is confi ned to the end of the choice chamber for 10 s as punishment for incorrect choices. The fi sh is put back into the center start chamber by opening the partition after the end of each trial. The differential reinforcement in the three-chamber task is punishment by swimming space restriction for incorrect choices and being left alone in the fullsized choice chamber for correct choices. To decrease the initial trial choice accuracy gives the subjects greater opportunity to improve with training. We have found that with this training against initial bias procedure fi sh show accuracy below random choice accuracy (50 % in the two-choice task).
The simplest paradigm is spatial discrimination learning, where the fi sh is consistently reinforced for choosing one side vs. the other. An initial assessment is made with each fi sh to determine its preferred side. Each fi sh is then trained against its preference, increasing the sensitivity of the task. The three-chamber task can also be used to assess color discrimination with the use of colored inserts at the ends of each side chamber. The locations of these can be randomly switched so that the fi sh is consistently rewarded for choosing one color regardless of the location. With both spatial and non-spatial discrimination, reversal learning can be assessed by training the fi sh to go to one side or one color and then switching the contingencies to the opposite choice being correct. Delayed spatial alternation can be tested as an index of memory. In this paradigm the spatial location of the correct choice is always opposite to the location of the previous response.
We have found in a series of studies that zebrafi sh will learn simple spatial discrimination, color discrimination, reversal learning as well as delayed spatial alternation (Arthur and Levin , 2001 ; Levin et al. , 2003 Levin et al. , , 2006a . Zebrafi sh will quickly learn spatial discrimination. We have found that a series of seven trials in a single session is suffi cient to demonstrate spatial learning. Zebrafi sh will also quickly learn nonspatial color discrimination with the use of colored stimuli placed at each choice side. The side of placement of these color stimuli is randomly switched to make their position location balanced over the Figure 9 The three-chamber task for assessing learning and memory (Eddins et al. , 2009 ) course of a test session. Over the course of four sessions of training zebrafi sh will learn non-spatial color discrimination. We have shown that zebrafi sh will also quickly learn reversal of color discrimination within a four-session period. Zebrafi sh learn delayed spatial alternation more slowly but they will reliably show this behavior such that drug effects on memory can be assessed.
As presented below, we have used the spatial discrimination and alternation procedures to assess the effects of nicotinic acetylcholine receptor manipulations on learning and memory in zebrafi sh.
The novel tank diving test
Zebrafi sh show a reproducible behavior of diving to the bottom when initially introduced into a novel environment and then over time increasing swimming to higher levels. This diving response by the fi sh would be adaptive to avoid predation from below. By diving to the bottom of the environment the zebrafi sh would have no open space below them and thus be protected from the approach of predators approaching from below. It is similar to the thigmotaxis that land animals, such as rodents, show when they stay near the walls when introduced into a novel open fi eld environment to eliminate a path of approach for predators. We have formalized observation of this behavior with the novel tank diving test to assess the effects of anxiolytic drugs.
The zebrafi sh were placed for testing in a 1.5-l plastic tank from the Aquatic Habitats system. The tanks were backlit and had a white sheet of plastic serve as a background for the imaging system ( Figure  10 , left panel). The test tanks were fi lled with home tank water 11.5 cm deep. The real time digital image of the fi sh swimming in the novel test tank was fed into the Noldus Image Analaysis Program, Etho Vision (Noldus Information and Technology, Wageningen, Netherlands) (Figure 10 , right panel) . Seconds per minute of the test spent in each third of the tank sectioned horizontally as well as swim path length per minute (log cm/min) were the dependent measures. The log of activity was taken to normalize the data. Because activity data are typically skewed it is appropriate that they are analyzed as the log of the raw score. The time spent in the bottom third of the tank was considered the index of anxiety. Choice of dwelling on the bottom was near a position of safety similar to the position choice of closed vs. open arms in the elevated plus maze and positions near the wall (thigmotaxis) vs. the center of an open fi eld with rodents (Karl et al. , 2003 ) . Similar to the elevated plus maze and open fi eld in rodents, there was also a separate total activity measure.
A study was conducted of the impact of home tank housing tank size on the dynamics of diving response during the novel tank diving test. The size of the housing tanks for the fi sh were 1.5 l and 3 l so that the effect of home tank size on the novel tank diving behavioral test could be compared. The tank used in the diving test was always the same sized 1.5-l tanks. In the studies of drug effects on diving, all of the fi sh were housed in 3-l tanks.
Drug administration
The behaviorally relevant dose ranges of nicotine and the other drugs tested were determined by pilot studies, which tested the effects of concentrations ranging from ineffective to those having acutely toxic effects. Detailed pharmacokinetics of nicotine and a variety of other drugs have not yet been characterized in zebrafi sh. Nicotine ditartrate was administered by immersing the zebrafi sh in a dosing tank with concentrations of 50 -800 mg/l nicotine for 3 min. The dose of nicotine was calculated on weight of the ditartrate salt. After nicotine exposure the fi sh were placed singly into a 3-l holding tank without nicotine for the interval between exposure and testing. A delay of 20 min was imposed between the end of dosing and the beginning of the test session. In the delay-response study the interval between the end of dosing and the beginning of testing ranged from 0 to 160 min. In the nicotine + mecamylamine experiment, nicotine (0 or 100 mg/l) was administered for 3 min, and then after 15 min in the recovery tank the fi sh were exposed to the nicotinic antagonist mecamylamine (0 or 200 mg/l) for 5 min. There was no nicotine exposure in either the home tank or the test chamber. All the fi sh were drug nai ve and each fi sh was tested only once in the spatial discrimination learning studies. In the delays spatial alternation study the fi sh underwent training and were then administered the nicotine doses on a repeated measures counterbalanced design with at least 2 days between doses.
For the novel tank diving test several anxiolytic and nicotinic drugs were tested for their acute effects on the zebrafi sh diving response. All of the drugs were administered by immersing the zebrafi sh in a beaker with fi xed drug concentrations for 3 min. The drugs were buspirone HCl (0, 3.125, 6.25, 12.5, 25 and 50 mg/l), diazepam HCl (0, 0.625, 1.5, 2.5, 5, 10 and 20 mg/l), chlordiazepoxide HCl (0, 0.625, 1.25, 2.5, 5, 10 and 20 mg/l), nicotine ditartrate (0, 50 and 100 mg/l), mecamylamine HCl (0 and 200 mg/l), dihydro-β -erythroidine HCl (DH β E, 0, 50, 100 and 200 mg/l), a nicotinic α 4 β 2 nicotinic receptor antagonist, and methyllycaconitine HCl (MLA, 0, 50, 100 and 200 mg/l), a nicotinic α 7 receptor antagonist. The doses of the drugs were calculated from the weight of the salt. A delay of 5 min was imposed between the end of dosing and the start of the trial. Tank water was used as the vehicle for all of the drugs except for diazepam which had tank water with 5 % DMSO as the vehicle to facilitate solution of the drug. The fi sh were exposed to the drug in a separate beaker and then were put into a holding tank without drug for the interval between exposure and testing.
Neurochemical analysis
After completing the behavioral task, neurochemical levels were assayed in homogenization tissue samples with HPLC. Briefl y, fi sh were anesthetized by submersion in 4 ° C aquarium water and euthanized by decapitation. The brains were rapidly excised Figure 10 Novel tank diving test for assessment of anxiolytic effects of drugs (Levin and Cerutti , 2008 ) . (A) The test tanks are 1.5-l thin tanks from the Aquatic Habitats system. The digital video camera images the fi sh location and conveys the images to the Noldus computer image analysis software. (B) The digitized swimming track of a fi sh over the course of the 5-min session. and homogenized (25 × vol/wt) in 0.1 n perchloric acid/100 m m EDTA:mobile phase (1:10). After column purifi cation, to remove solid cellular particulate, samples were diluted in mobile phase (1:10) and 20 µ l were analyzed for monoamine levels with HPLC.
The HPLC system consisted of an isocratic pump (model LC1120, GBC Separations, Hubbardston, MA, USA), a Rheodyne injector (model 7725i) with a 20 µ l PEEK loop, and an INTRO amperometric detector (Antec Leyden, Zoeterwoude, Netherlands). The electrochemical fl ow cell (model VT 03, Antec Leyden) had a 3-mm glassy carbon working electrode with a 25 µ m spacer, and a Ag/AgCl reference electrode. The cell potential was set at 700 mV. The signal was fi ltered with a low pass in-line noise killer, LINK (Antec Leyden) set at a 14-s peak width and a cut-off frequency of 0.086 Hz. The signal is integrated using the EZChrom elite chromatography software (Scientifi c Software Inc., Lincolnwood, IL, USA). The injector, fl ow cell and analytical column were placed in the Faraday-shielded compartment of the detector where the temperature is maintained at 30 ° C. The stationary phase was a reverse phase BDS Hypersil C18 column 100 mm × 2.1 mm, with 5 µ m particle size and 120 Å pore size (Keystone Scientifi c, Waltham, MA, USA). The mobile phase was commercially purchased (ESA, MD-TM mobile phase, Chelmsford, MA, USA). The mobile phase was continually degassed with a Degasys Populaire on-line degasser (Sanwa Tsusho Co. Ltd., Tokyo, Japan) and delivered at a fl ow rate of 0.5 ml/min.
Data analysis
Repeated-measures analysis of variance tests were used to assess the effects of the drugs and their interactions. Planned comparisons were made between treatments and control conditions. The fi nal threshold for all effects was p < 0.05 (two-tailed).
